Journal of Pharmaceutical Sciences

Article	Citations
Addressing the Cold Reality of mRNA Vaccine Stability	325
Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors	137
A review of Formulations of Commercially Available Antibodies	134
Delivery of Therapeutics from Layer-by-Layer Electrospun Nanofiber Matrix for Wound Healing: An Update	97
Sodium Alginate as a Pharmaceutical Excipient: Novel Applications of a Well-known Polymer	82
Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy	70
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case	69
Nitrosamine Contamination in Pharmaceuticals: Threat, Impact, and Control	69
Implementation of a Human Renal Proximal Tubule on a Chip for Nephrotoxicity and Drug Interaction Studies	61
The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies	61
Predicting With Confidence: Using Conformal Prediction in Drug Discovery	58
3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities	58
Rapid Polysorbate 80 Degradation by Liver Carboxylesterase in a Monoclonal Antibody Formulated Drug Substance at Early Stage Development	55
Selective Laser Sintering 3-Dimensional Printing as a Single Step Process to Prepare Amorphous Solid Dispersion Dosage Forms for Improved Solubility and Dissolution Rate	54
Cyclodextrins in Parenteral Formulations	51
Freeze-Drying of Pharmaceutical and Nutraceutical Nanoparticles: The Effects of Formulation and Technique Parameters on Nanoparticles Characteristics	50
How can Electrospinning Further Service Well for Pharmaceutical Researches?	48
The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines	44
Capsaicin Loaded Solid SNEDDS for Enhanced Bioavailability and Anticancer Activity: In-Vitro, In-Silico, and In-Vivo Characterization	44
Novel Chitosan-Coated Niosomal Formulation for Improved Management of Bacterial Conjunctivitis: A Highly Permeable and Efficient Ocular Nanocarrier for Azithromycin	43
Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis?	43
Comprehensive Size Distribution and Composition Analysis of Adeno-Associated Virus Vector by Multiwavelength Sedimentation Velocity Analytical Ultracentrifugation	43
Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies	41
The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals	41
Preparation and Characterization of Docetaxel-PLGA Nanoparticles Coated with Folic Acid-chitosan Conjugate for Cancer Treatment	41

Identification and Characterization of Polysorbate-Degrading Enzymes in a Monoclonal Antibody Formulation	40
Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study	40
Perspectives About Self-Immolative Drug Delivery Systems	39
Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing	38
A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products	38
Industry Perspective on the use and Characterization of Polysorbates for Biopharmaceutical Products Part 1: Survey Report on Current State and Common Practices for Handling and Control of Polysorbates	37
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes	36
Curcumin Loaded Chitosan-Protamine Nanoparticles Revealed Antitumor Activity Via Suppression of NF-κB, Proinflammatory Cytokines and Bcl-2 Gene Expression in the Breast Cancer Cells	36
Application of Extrusion-Based 3D Printed Dosage Forms in the Treatment of Chronic Diseases	35
A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics	35
Curcumin Encapsulated Casein Nanoparticles: Enhanced Bioavailability and Anticancer Efficacy	35
Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report	35
Human Serum Albumin as Multifunctional Nanocarrier for Cancer Therapy	35
Cubosomes as a Potential Oral Drug Delivery System for Enhancing the Hepatoprotective Effect of Coenzyme Q10	34
Predicting the Permeability of Macrocycles from Conformational Sampling – Limitations of Molecular Flexibility	33
Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies	33
Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report	33
Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation	33
Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation Strategies	33
Design and Investigation of Penetrating Mechanism of Octaarginine-Modified Alginate Nanoparticles for Improving Intestinal Insulin Delivery	33
Formulation Development, In Vitro and In Vivo Evaluation of Topical Hydrogel Formulation of Econazole Nitrate-Loaded β-Cyclodextrin Nanosponges	32
3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers	32
Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation	32
The Effects of Solid and Liquid Lipids on the Physicochemical Properties of Nanostructured Lipid Carriers	32
Warp-Speed Covid-19 Vaccine Development: Beneficiaries of Maturation in Biopharmaceutical Technologies and Public-Private Partnerships	30
Polysorbate Degradation and Particle Formation in a High Concentration mAb: Formulation Strategies to Minimize Effect of Enzymatic Polysorbate Degradation	30
Machine Learning Feature Selection for Predicting High Concentration Therapeutic Antibody Aggregation	30
Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study	30
Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Bioequivalence Safe-space for Ribociclib which has Permeation Rate-controlled Absorption	30
Applications of Machine Learning in Solid Oral Dosage Form Development	30
In-Use Interfacial Stability of Monoclonal Antibody Formulations Diluted in Saline i.v. Bags	29
Nanoemulsion for Improving the Oral Bioavailability of Hesperetin: Formulation Optimization and Absorption Mechanism	29
Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations	29
Investigation of the Pristine and Functionalized Carbon Nanotubes as a Delivery System for the Anticancer Drug Dacarbazine: Drug Encapsulation	29
Current Approaches of Preservation of Cells During (freeze-) Drying	28
Processability of poly(vinyl alcohol) Based Filaments With Paracetamol Prepared by Hot-Melt Extrusion for Additive Manufacturing	28
Contemporary Formulation Development for Inhaled Pharmaceuticals	27
99mTc-Methionine Gold Nanoparticles as a Promising Biomaterial for Enhanced Tumor Imaging	27
Overview of Humira® Biosimilars: Current European Landscape and Future Implications	27
Exploration and Preparation of Patient-specific Ciprofloxacin Implants Drug Delivery System Via 3D Printing Technologies	27
Characterization of Polysorbate 80 by Liquid Chromatography-Mass Spectrometry to Understand Its Susceptibility to Degradation and Its Oxidative Degradation Pathway	26
Comprehensive Development in Organ-On-A-Chip Technology	26
Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations	25
Glass Leachables as a Nucleation Factor for Free Fatty Acid Particle Formation in Biopharmaceutical Formulations	25
Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States	25
Green Synthesis of Ciprofloxacin-Loaded Cerium Oxide/Chitosan Nanocarrier and its Activity Against MRSA-Induced Mastitis	25
Designing, Optimization and Characterization of Trifluralin Transfersomal Gel to Passively Target Cutaneous Leishmaniasis	25
In Silico Models of Human PK Parameters. Prediction of Volume of Distribution Using an Extensive Data Set and a Reduced Number of Parameters	25
Fabrication of Rapidly Separable Microneedles for Transdermal Delivery of Metformin on Diabetic Rats	25
Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells	25

Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals	24
Antipsychotic Potential and Safety Profile of TPGS-Based Mucoadhesive Aripiprazole Nanoemulsion: Development and Optimization for Nose-To-Brain Delivery	24
Molecular Dynamics Simulation to Uncover the Mechanisms of Protein Instability During Freezing	24
Amelioration of Tumor Targeting and In Vivo Biodistribution of 99mTc-Methotrexate-Gold Nanoparticles (99mTc-Mex-AuNPs)	23
Tolerability of risk: A commentary on the nitrosamine contamination issue	23
Prediction of Total Drug Clearance in Humans Using Animal Data: Proposal of a Multimodal Learning Method Based on Deep Learning	23
A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive?	23
Improvement of Oral Bioavailability and Anti-Tumor Effect of Zingerone Self-Microemulsion Drug Delivery System	23
Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report	22
Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the Future	22
N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental Observations	22
Re-Envisioning Pharmaceutical Manufacturing: Increasing Agility for Global Patient Access	22
Cyrene™ as an Alternative Sustainable Solvent for the Preparation of Poly(lactic-co-glycolic acid) Nanoparticles	22
Voriconazole Ternary Micellar Systems for the Treatment of Ocular Mycosis: Statistical Optimization and In Vivo Evaluation	22
Fabrication of All-Trans Retinoic Acid loaded Chitosan/Tripolyphosphate Lipid Hybrid Nanoparticles as a Novel Oral Delivery Approach for Management of Diabetic Nephropathy in Rats	22
Molecular Dynamics Simulations Reveal Membrane Interactions for Poorly Water-Soluble Drugs: Impact of Bile Solubilization and Drug Aggregation	22
In Vitro and In Vivo Evaluation of 3D Printed Capsules with Pressure Triggered Release Mechanism for Oral Peptide Delivery	21
Prediction Machines: Applied Machine Learning for Therapeutic Protein Design and Development	21
Release Mechanisms of Amorphous Solid Dispersions: Role of Drug-Polymer Phase Separation and Morphology	21
An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics	21
The Complexity of the Blood-Brain Barrier and the Concept of Age-Related Brain Targeting: Challenges and Potential of Novel Solid Lipid-Based Formulations	21
Simultaneous Monitoring and Comparison of Multiple Product Quality Attributes for Cell Culture Processes at Different Scales Using a LC/MS/MS Based Multi-Attribute Method	21
Ritonavir Form III: A New Polymorph After 24 Years	21
Resveratrol-Loaded Vesicular Elastic Nanocarriers Gel in Imiquimod-Induced Psoriasis Treatment: In Vitro and In Vivo Evaluation	21
In Vitro Biopredictive Methods: A Workshop Summary Report	20
Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations	20
Impact of Polysorbate 80 Grade on the Interfacial Properties and Interfacial Stress Induced Subvisible Particle Formation in Monoclonal Antibodies	20
Proteins on the Rack: Mechanistic Studies on Protein Particle Formation During Peristaltic Pumping	20
Cationic Polymeric Nanoparticles for Improved Ocular Delivery and Antimycotic Activity of Terconazole	20
Development, Optimization, and Antifungal Assessment of Ocular Gel Loaded With Ketoconazole Cubic Liquid Crystalline Nanoparticles	20
Application of Thermodynamic Phase Diagrams and Gibbs Free Energy of Mixing for Screening of Polymers for Their Use in Amorphous Solid Dispersion Formulation of a Non-Glass-Forming Drug	19
Intradermal Administration of Influenza Vaccine with Trehalose and Pullulan-Based Dissolving Microneedle Arrays	19
Blood-Brain Barrier Permeability of Asiaticoside, Madecassoside and Asiatic Acid in Porcine Brain Endothelial Cell Model	19
pH-Dependent Phase Behavior and Stability of Cationic Lipid–mRNA Nanoparticles	19
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment	19
Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3	18
Cereal-Based 3D Printed Dosage Forms for Drug Administration During Breakfast in Pediatric Patients within a Hospital Setting	18
A composite System Combining Self-Targeted Carbon Dots and Thermosensitive Hydrogels for Challenging Ocular Drug Delivery	18
Mannitol as an Excipient for Lyophilized Injectable Formulations	18
Combinatorial Effect of Doxorubicin Entrapped in Alginate-Chitosan Hybrid Polymer and Cerium Oxide Nanocomposites on Skin Cancer Management in Mice	18
Dexamethasone Sodium Phosphate Loaded Modified Cyclodextrin Based Nanoparticles: An Efficient Treatment for Rheumatoid Arthritis	18
Characterization of Spray Dried Particles Through Microstructural Imaging	18
Doxorubicin-loaded, pH-sensitive Albumin Nanoparticles for Lung Cancer Cell Targeting	18
A Fast and Non-destructive Terahertz Dissolution Assay for Immediate Release Tablets	18
Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model	18
Amelioration of Endotoxin-Induced Uveitis in Rabbit by Topical Administration of Tacrolimus Proglycosome Nano-Vesicles	17
Stress Factors in Primary Packaging, Transportation and Handling of Protein Drug Products and Their Impact on Product Quality	17
Amorphous Drug–Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Challenging Case of Lumefantrine-PAA	17
Evaluation of In Vivo toxicity of Novel Biosurfactant from Candida parapsilosis loaded in PLA-PEG Polymeric Nanoparticles	17
Amorphous Solid Dispersions of Felodipine and Nifedipine with Soluplus®: Drug-Polymer Miscibility and Intermolecular Interactions	17
3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen	17
Near UV and Visible Light Photo-Degradation Mechanisms in Citrate Buffer: One-Electron Reduction of Peptide and Protein Disulfides promotes Oxidation and Cis/Trans Isomerization of Unsaturated Fatty A	17
CFD-DEM -DDM Model for Spray Coating Process in a Wurster Coater	17
Quantitation of Trace Levels of DNA Released from Disrupted Adeno-Associated Virus Gene Therapy Vectors	17
Carboplatin Niosomal Nanoplatform for Potentiated Chemotherapy	17
The Drug Release Kinetics and Anticancer Activity of the GO/PVA-Curcumin Nanostructures: The Effects of the Preparation Method and the GO Amount	17
Mechanistic Models for USP2 Dissolution Apparatus, Including Fluid Hydrodynamics and Sedimentation	17
Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions	17
Utility of Physiologically Based Biopharmaceutics Modeling (PBBM) in Regulatory Perspective: Application to Supersede f2, Enabling Biowaivers & Creation of Dissolution Safe Space	16
Transport and Lymphatic Uptake of Biotherapeutics Through Subcutaneous Injection	16
Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice	16
Systemic Inflammation Induced Changes in Protein Expression of ABC Transporters and Ionotropic Glutamate Receptor Subunit 1 in the Cerebral Cortex of Familial Alzheimer`s Disease Mouse Model	16
Synergistic Computational Modeling Approaches as Team Players in the Game of Solubility Predictions	16
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Carbamazepine	16
Predicting Oral Absorption for Compounds Outside the Rule of Five Property Space	16
The Impact of Formulation Composition and Process Settings of Traditional Batch Versus Continuous Freeze-Drying On Protein Aggregation	16
Assessing and Predicting Physical Stability of Emulsion-Based Topical Semisolid Products: A Review	16
Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer	16
Trouble With the Neighbor During Freeze-Drying: Rivalry About Energy	16
Pharmacokinetic and Pharmacodynamic Evaluation of Gemifloxacin Chitosan Nanoparticles As an Antibacterial Ocular Dosage Form	16
Comparison of Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody	16
Formulation and Processing Strategies which Underpin Susceptibility to Matrix Crystallization in Amorphous Solid Dispersions	16
Intra-Articular Dual Drug Delivery for Synergistic Rheumatoid Arthritis Treatment	16
Continuous Manufacturing of Ketoprofen Delayed Release Pellets Using Melt Extrusion Technology: Application of QbD Design Space, Inline Near Infrared, and Inline Pellet Size Analysis	16
Novel Insights to Enhance Therapeutics With Acyclovir in the Management of Herpes Simplex Encephalitis	16
Application of PC-SAFT EOS for Pharmaceuticals: Solubility, Co-Crystal, and Thermodynamic Modeling	16
Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term Dosing in Patients	16
Functionalized Graphene Oxide as Drug Delivery Systems for Platinum Anticancer Drugs	16
Comparison of Different Chitosan Lipid Nanoparticles for Improved Ophthalmic Tetrandrine Delivery: Formulation, Characterization, Pharmacokinetic and Molecular Dynamics Simulation	16
Effects of Transportation of IV Bags Containing Protein Formulations Via Hospital Pneumatic Tube System: Particle Characterization by Multiple Methods	16

Pregnancy-Related Hormones Increase Nifedipine Metabolism in Human Hepatocytes by Inducing CYP3A4 Expression	16
Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability	15
Understanding the Impact of Multi-factorial Composition on Efficient Loading of the Stable Ketoprofen Nanoparticles on Orodispersible Films Using Box-Behnken Design	15
Addressing Patient to Patient Variability for Autologous CAR T Therapies	15
Dosage Adjustment for Ceftazidime in Pediatric Patients With Renal Impairment Using Physiologically Based Pharmacokinetic Modeling	15
Considerations in the Development of Physically Stable High Drug Load API- Polymer Amorphous Solid Dispersions in the Glassy State	15
Transdermal Route: A Viable Option for Systemic Delivery of Antidepressants	15
Uptake Kinetics Of Liposomal Formulations of Differing Charge Influences Development of in Vivo Dendritic Cell Immunotherapy	15
Ultrasensitive Quantification of Drug-metabolizing Enzymes and Transporters in Small Sample Volume by Microflow LC-MS/MS	15
Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective	15
Evaluation of In Vitro Tools to Predict the In Vivo Absorption of Biopharmaceuticals Following Subcutaneous Administration	15
A Highly Sensitive LC-MS/MS Method for Targeted Quantitation of Lipase Host Cell Proteins in Biotherapeutics	15
Industry White Paper: Contemporary Opportunities and Challenges in Characterizing Crystallinity in Amorphous Solid Dispersions	15
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab	15
Patient-Centric Product Development: A Summary of Select Regulatory CMC and Device Considerations	15
Improved Solubility and Oral Absorption of Emodin-Nicotinamide Cocrystal Over Emodin with PVP as a Solubility Enhancer and Crystallization Inhibitor	15
Extended Characterization and Impact of Visible Fatty Acid Particles - A Case Study With a mAb Product	15
A Drug–Drug Cocrystal of Dihydromyricetin and Pentoxifylline	15
Size Distribution Analysis of the Adeno-Associated Virus Vector by the c(s) Analysis of Band Sedimentation Analytical Ultracentrifugation with Multiwavelength Detection	15
Disintegrant Selection in Hydrophobic Tablet Formulations	15
Development of Lecithin/Chitosan Nanoparticles for Promoting Topical Delivery of Propranolol Hydrochloride: Design, Optimization and In-Vivo Evaluation	15
Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration	15
Tabletability Flip – Role of Bonding Area and Bonding Strength Interplay	15
Application of First Principles Primary Drying Model to Lyophilization Process Design and Transfer: Case Studies From the Industry	15
The Impact of Product and Process Related Critical Quality Attributes on Immunogenicity and Adverse Immunological Effects of Biotherapeutics	15
Rational Selection of Bio-Enabling Oral Drug Formulations – A PEARRL Commentary	15
Diffusion Modeling and In Vitro Release Kinetics Studies of Curcumin−Loaded Superparamagnetic Nanomicelles in Cancer Drug Delivery System	15
Dehydration and Rehydration Mechanisms of Pharmaceutical Crystals: Classification Of Hydrates by Activation Energy	15
Evaluation of Prediction Accuracy for Volume of Distribution in Rat and Human Using In Vitro, In Vivo, PBPK and QSAR Methods	15
Composing Novel Diclofenac Potassium and l-Proline Salt Cocrystal as a Strategy to Increase Solubility and Dissolution	15
Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances	14
Determination of Holdup Volume and Transient Contact Compatibility of Closed System Transfer Devices for a Reconstituted Lyophilized Drug Product	14
Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens	14
Towards Virtual Bioequivalence Studies for Oral Dosage Forms Containing Poorly Water-Soluble Drugs: A Physiologically Based Biopharmaceutics Modeling (PBBM) Approach	14
Effect of Conjugation Site and Technique on the Stability and Pharmacokinetics of Antibody-Drug Conjugates	14
Best Practices for Aggregate Quantitation of Antibody Therapeutics by Sedimentation Velocity Analytical Ultracentrifugation	14
Strategies for Setting Patient-Centric Commercial Specifications for Biotherapeutic Products	14
Preparation, Physical Characterization, Pharmacokinetics and Anti-Hyperglycemic Activity of Esculetin-Loaded Mixed Micelles	14
Challenges for Cell-Based Medicinal Products From a Pharmaceutical Product Perspective	14
Acoustic Droplet Ejection and Open Port Interface for Rapid Analysis of Metabolic Stability Assays	14
Formulation and In-Vitro Characterisation of Cross-Linked Amphiphilic Guar Gum Nanocarriers for Percutaneous Delivery of Arbutin	14
Probing Microenvironmental Acidity in Lyophilized Protein and Vaccine Formulations Using Solid-state NMR Spectroscopy	14
Aqueous Dissolution and Dispersion Behavior of Polyvinylpyrrolidone Vinyl Acetate-based Amorphous Solid Dispersion of Ritonavir Prepared by Hot-Melt Extrusion with and without Added Surfactants	14
Exploring the Formation Mechanism of Coamorphous Andrographolide-Oxymatrine Based on Molecular Dynamics and Spectroscopy	14
Lactosome-Conjugated siRNA Nanoparticles for Photo-Enhanced Gene Silencing in Cancer Cells	14
Effects of Linkers on the Development of Liposomal Formulation of Cholesterol Conjugated Cobalt Bis(dicarbollides)	14
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside	14
Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter	14
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2	13
Current Trends in API Co-Processing: Spherical Crystallization and Co-Precipitation Techniques	13
A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions	13
Factors Affecting Stability of RNA – Temperature, Length, Concentration, pH, and Buffering Species	13
Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality	13
Multiple Transport Mechanisms Involved in the Intestinal Absorption of Metformin: Impact on the Nonlinear Absorption Kinetics	13
A Kinetic Model for Spray-Freezing of Pharmaceuticals	13
The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations	13
Polymer Coated Polymeric (PCP) Microneedles for Controlled Delivery of Drugs (Dermal and Intravitreal)	13
The Role of Titanium Dioxide (E171) and the Requirements for Replacement Materials in Oral Solid Dosage Forms: An IQ Consortium Working Group Review	13
Functional Characterization of Extracellular Vesicles from Baker's Yeast Saccharomyces Cerevisiae as a Novel Vaccine Material for Immune Cell Maturation	13
Development of Gene Therapy Vectors: Remaining Challenges	13
Aerosol Inhalation Delivery of Triazavirin in Mice: Outlooks for Advanced Therapy Against Novel Viral Infections	13
Determining The Role of Surface Glycans in The Pharmacokinetics of Small Extracellular Vesicles	13
Synthesis of Layered Double Hydroxides Intercalated With Drugs for Controlled Release: Successful Intercalation of Ibuprofen and Failed Intercalation of Paracetamol	13
A Magnetic T7 Peptide&AS1411 Aptamer-Modified Microemulsion for Triple Glioma-Targeted Delivery of Shikonin and Docetaxel	13
In situ Formed Implants, Based on PLGA and Eudragit Blends, for Novel Florfenicol Controlled Release Formulations	13
Lamination of Pharmaceutical Tablets: Classification and Influence of Process Parameters	13
Computer Simulation of Skin Permeability of Hydrophobic and Hydrophilic Chemicals – Influence of Follicular Pathway	13
Product-Specific Impact of Viscosity Modulating Formulation Excipients During Ultra-High Concentration Biotherapeutics Drug Product Development	13
Machine Learning and Accelerated Stress Approaches to Differentiate Potential Causes of Aggregation in Polyclonal Antibody Formulations During Shipping	13
Effect of Doxorubicin Release Rate From Polyethylene Glycol-Modified Liposome on Anti-tumor Activity in B16-BL6 Tumor-Bearing Mice	13
The Provisional No-Effect Threshold of Sugar Alcohols on Oral Drug Absorption Estimated by Physiologically Based Biopharmaceutics Model	13
A Rapid, Small-Volume Approach to Evaluate Protein Aggregation at Air-Water Interfaces	13
Lipid nano-carriers loaded with Cannabis sativa extract for epilepsy treatment – in vitro characterization and in vivo efficacy studies	13
Galactosylated Chitosan Coated Liposomes of Ledipasvir for Liver Targeting: Chemical Synthesis, Statistical Optimization, In-vitro and In-vivo evaluation	13
Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody	13
Lysine-Based Biodegradable Surfactants: Increasing the Lipophilicity of Insulin by Hydrophobic Ion Paring	13
A Mass Spectrometric Characterization of Light-Induced Modifications in Therapeutic Proteins	13
Influence of Protein Adsorption on Aggregation in Prefilled Syringes	13
An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug Products	12
Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection	12
Characterization of N-Terminal Glutamate Cyclization in Monoclonal Antibody and Bispecific Antibody Using Charge Heterogeneity Assays and Hydrophobic Interaction Chromatography	12
Advanced Formulations/Drug Delivery Systems for Subcutaneous Delivery of Protein-Based Biotherapeutics	12
Blockade of Microglial Kv1.3 Potassium Channels by the Peptide HsTX1[R14A] Attenuates Lipopolysaccharide-mediated Neuroinflammation	12
Beyond Brittle/Ductile Classification: Applying Proper Constitutive Mechanical Metrics to Understand the Compression Characteristics of Pharmaceutical Materials	12
Design and Optimization of Stimuli-responsive Emulsion-filled Gel for Topical Delivery of Copaiba Oil-resin	12
Polymeric Lipid Hybrid Nanoparticles as a Delivery System Enhance the Antitumor Effect of Emodin in Vitro and in Vivo	12
Protein A does not induce allosteric structural changes in an IgG1 antibody during binding	12
The Amorphous Quercetin/ Hydroxypropylmethylcellulose Acetate Succinate Solid Dispersions Prepared by Co-Precipitation Method to Enhance Quercetin Dissolution	12
Evaluation of tableting performance of Poly (ethylene oxide) in abuse-deterrent formulations using compaction simulation studies	12
Impact of Surfactants on the Functionality of Prefilled Syringes	12
Improvement of New Dianionic Ionic Liquids vs Monoanionic in Solubility of Poorly Water-Soluble Drugs	12
A Systematic Approach to Evaluating Closed System Drug-Transfer Devices During Drug Product Development	12
Effect of Tartrazine as Photoabsorber for Improved Printing Resolution of 3D Printed “Ghost Tablets”: Non-Erodible Inert Matrices	12
The Future of CMC Regulatory Submissions: Streamlining Activities Using Structured Content and Data Management	12
Physicochemical and Biological Evaluation of Curdlan-Poly(Lactic-Co-Glycolic Acid) Nanoparticles as a Host-Directed Therapy Against Mycobacterium Tuberculosis	12